Suchergebnisse - "Ayerbe-Algaba, Rafael"

PubPharm (20)

1

Repurposing of the tamoxifen metabolites to treat methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecalis infections

enthalten in: bioRxiv.org | 2022

von Miró-Canturri, A. | Vila-Domínguez, A. | Ayerbe-Algaba, R. | +3

2

Impact of the immune response modification by lysophosphatidylcholine in the efficacy of antibiotic therapy of experimental models of peritoneal sepsis and pneumonia by Pseudomonas aeruginosa : LPC therapeutic effect in combined therapy

enthalten in: Enfermedades infecciosas y microbiologia clinica (English ed.) | 2022

von Parra-Millán, R. | Jiménez-Mejías, M. | Ayerbe-Algaba, R. | +5

3

Corrigendum : Drug Repurposing for the Treatment of Bacterial and Fungal Infections

enthalten in: Frontiers in microbiology | 2022

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Smani, Y.

ErratumFor: Front Microbiol. 2019 Jan 28;10:41. - PMID 30745898

4

Tamoxifen repurposing to combat infections by multidrug-resistant Gram-negative bacilli

enthalten in: bioRxiv.org | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | del Toro, R. | +2

5

Repurposing of the Tamoxifen Metabolites to Treat Methicillin-Resistant Staphylococcus epidermidis and Vancomycin-Resistant Enterococcus faecalis Infections

enthalten in: Microbiology spectrum | 2021

von Miró-Canturri, A. | Vila-Domínguez, A. | Caretero-Ledesma, M. | +4

6

Potential Tamoxifen Repurposing to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

enthalten in: Pharmaceuticals (Basel, Switzerland) | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Del Toro, R. | +3

7

Repurposing of the Tamoxifen Metabolites to Combat Infections by Multidrug-Resistant Gram-Negative Bacilli

enthalten in: Antibiotics (Basel, Switzerland) | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Vila-Domínguez, A. | +3

8

Efficacy of Lysophosphatidylcholine as Direct Treatment in Combination with Colistin against Acinetobacter baumannii in Murine Severe Infections Models

enthalten in: Antibiotics (Basel, Switzerland) | 2021

von Miró-Canturri, A. | Ayerbe-Algaba, R. | Jiménez-Mejías, M. | +2

9

AOA-2 Derivatives as Outer Membrane Protein A Inhibitors for Treatment of Gram-Negative Bacilli Infections

enthalten in: Frontiers in microbiology | 2021

von Ayerbe-Algaba, R. | Bayó, N. | Verdú, E. | +6

10

Impact of the Immune Response Modification by Lysophosphatidylcholine in the Efficacy of Antibiotic Therapy of Experimental Sepsis and Pneumonia by Pseudomonas aeruginosa

enthalten in: Preprints.org | 2020

von Parra-Millán, R. | Jiménez-Mejías, M. | Ayerbe-Algaba, R. | +5